Nexalin Technology (NXL) Launches Advanced Virtual Clinic for Military Study | NXL Stock News

Author's Avatar
5 days ago

Nexalin Technology, Inc. (NXL, Financial) has successfully completed and launched the first five phases of its unique virtual clinic and digital research infrastructure. This significant development was unveiled at the University of California, San Diego, marking a pivotal step in supporting patient recruitment for the newly announced traumatic brain injury (TBI) and post-traumatic stress disorder (PTSD) military study.

The virtual clinic is designed to handle real-time data collection, remote monitoring, and clinical supervision of the HALO headset, enhancing both research and patient care applications. Importantly, it allows both civilian and military patients to receive treatments privately at home, while ensuring compliance and monitoring through clinical research protocols.

With the integration of artificial intelligence, Nexalin's system offers a comprehensive digital ecosystem that facilitates clinical research, patient progress tracking, and optimization of treatment delivery within a secure, cloud-based framework. This milestone follows the initial phase, launched in December 2024, which introduced critical components like the Electronic Data Capture platform and the Patient Monitoring System.

The completion of phases one through five represents a significant leap forward, enabling Nexalin to efficiently conduct fully remote research studies and streamline patient care through its non-invasive DIFS technology.

Wall Street Analysts Forecast

1915040670893109248.png

Based on the one-year price targets offered by 1 analysts, the average target price for Nexalin Technology Inc (NXL, Financial) is $5.00 with a high estimate of $5.00 and a low estimate of $5.00. The average target implies an upside of 187.36% from the current price of $1.74. More detailed estimate data can be found on the Nexalin Technology Inc (NXL) Forecast page.

Based on the consensus recommendation from 1 brokerage firms, Nexalin Technology Inc's (NXL, Financial) average brokerage recommendation is currently 2.0, indicating "Outperform" status. The rating scale ranges from 1 to 5, where 1 signifies Strong Buy, and 5 denotes Sell.

Disclosures

I/We may personally own shares in some of the companies mentioned above. However, those positions are not material to either the company or to my/our portfolios.